Jing Zhen
Impact in
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
- Pharmacology top 5%
- Hibiscus Plant Research Studies
Papers in
-
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 3
- Protein purification and stability 2
-
- Cancer-related molecular mechanisms research 6
- Cancer, Lipids, and Metabolism 3
- Co-authors
- Qingli Wu (6 shared papers)James E. Simon (5 shared papers)Yue Guo (2 shared papers)Chi‐Tang Ho (1 shared paper)Yadong Qi (1 shared paper)Min‐Hsiung Pan (1 shared paper)Thomas S. Villani (1 shared paper)Kai Jiao (5 shared papers)
- Journals
- Aging (5 papers)Cell Biology and Toxicology (2 papers)Technology in Cancer Research & Treatment (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Antibodies (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Jing Zhen
44 papers receiving 886 citations
Jing Zhen's Hit Papers
Peers
Comparison fields: 5 of 118
- Biochemistry 114
- Pharmacology 125
- Microbiology 8
- Cancer Research 98
- Molecular Biology 390
Countries citing papers authored by Jing Zhen
This map shows the geographic impact of Jing Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Zhen more than expected).
Fields of papers citing papers by Jing Zhen
This network shows the impact of papers produced by Jing Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Zhen. The network helps show where Jing Zhen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Zhen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 179 | |
| 2 | The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases Hit paper breakdown → | 2023 | 121 |
| 3 | 2014 | 73 | |
| 4 | 2017 | 58 | |
| 5 | 2020 | 43 | |
| 6 | 2017 | 36 | |
| 7 | 2010 | 34 | |
| 8 | 2015 | 32 | |
| 9 | 2019 | 28 | |
| 10 | 2020 | 27 | |
| 11 | 2023 | 21 | |
| 12 | 2021 | 21 | |
| 13 | 2018 | 20 | |
| 14 | 2022 | 18 | |
| 15 | 2020 | 14 | |
| 16 | Deubiquitinase ZRANB1 drives hepatocellular carcinoma progression through SP1-LOXL2 axis. | 2021 | 14 |
| 17 | 2018 | 13 | |
| 18 | Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients. | 2001 | 11 |
| 19 | 2021 | 11 | |
| 20 | 2018 | 10 |
About Jing Zhen
Jing Zhen is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Plant Science and Organic Chemistry, having authored 44 papers that have together received 907 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Ferroptosis and cancer prognosis (5 papers), RNA modifications and cancer (4 papers), Cancer, Lipids, and Metabolism (3 papers), Natural Antidiabetic Agents Studies (3 papers), Ubiquitin and proteasome pathways (3 papers), Protein purification and stability (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Biochemistry (114 citations), Pharmacology (125 citations), Microbiology (8 citations), Cancer Research (98 citations) and Molecular Biology (390 citations). Jing Zhen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Qingli Wu, James E. Simon, Yue Guo, Chi‐Tang Ho, Yadong Qi, Min‐Hsiung Pan, Thomas S. Villani, Kai Jiao, Chunyan Hu and Yujie Dai. Their work appears in journals such as Aging, Cell Biology and Toxicology, Technology in Cancer Research & Treatment, Bioorganic & Medicinal Chemistry Letters and Antibodies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.